Unknown

Dataset Information

0

Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors.

ABSTRACT:

SUBMITTER: Razafimahatratra SL 

PROVIDER: S-EPMC8439619 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors.
| S-EPMC7877494 | biostudies-literature
Unknown SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.
| S-EPMC8176015 | biostudies-literature
Unknown Seroprevalence of Anti-SARS-CoV-2 Antibodies in Blood Donors from Nuevo Leon State, Mexico, during 2020: A Retrospective Cross-Sectional Evaluation.
| S-EPMC8310175 | biostudies-literature
Unknown SARS-CoV-2 seroprevalence among blood donors, Chongqing, China, January 1 to May 31, 2020.
| S-EPMC8743574 | biostudies-literature
Unknown Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era.
| S-EPMC9045380 | biostudies-literature
Unknown SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
| S-EPMC8013879 | biostudies-literature
Unknown Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors.
| S-EPMC8208066 | biostudies-literature
Unknown SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan.
| S-EPMC8092034 | biostudies-literature
Unknown Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening".
| S-EPMC8081167 | biostudies-literature
Unknown Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands.
| S-EPMC7665189 | biostudies-literature